Real-world study evaluates efficacy and safety of switched insulin degludec/insulin aspart in Korean adults with type 2 diabetes mellitus, highlighting clinical outcomes in routine care.
This study investigated the real-world efficacy and safety of insulin degludec/insulin aspart (IDegAsp) in Korean adults with type 2 diabetes mellitus (T2DM), whose insulin treatment was switched to IDegAsp.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: